Drug Science

“Drug Science is the leading independent scientific body on drugs in the UK. We work to provide clear, evidence-based information without political or commercial interference.”

The website provides independent information about different drugs (here) and commentary on drug policy (in the UK, here).

The mission of Drug Science is “To provide an evidence base free from political or commercial influence, creating the foundation for sensible and effective drug laws. Equipping the public, media and policy makers with the knowledge and resources to enact positive change.”

Key Staff

David Nutt – Founder and on Scientific Committee

David Badcock – CEO

Anne Schlag – Head of Research

Chloe Sakal – Project 21 (see below) Director and Clinical Lead

James Bunn – Communications Manager

Pallab Seth – Managing Director Drug Science Journal

Projects

Project 21 – Europe’s first and biggest national medical cannabis registry, to create the largest body of evidence for the effectiveness and tolerability of medical cannabis

MCDA modeling – Looking at the societal and personal harm of different drugs (MDMA, LSD, psilocybin were shown to be least harmful)

Medical Psychedelics Working Group – “a new working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes

The Drug Science Podcast – This rationalist podcast from David Nutt and his team at Drug Science explores different drugs and the science and policy surrounding them

See all podcasts in an overview here

Become a psychedelic insider!

With a Blossom membership you will always be in the know.

📰 Twice a week newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

See all benefits